Zhang Daogong, Fan Zhaomin, Han Yuechen, Li Yawei, Wang Haibo
Department of Otorhinolaryngology Head and Neck Surgery, Provincial Hospital affiliated to Shandong University, Shandong Provincial Key Laboratory of Otology, Jinan 250021, China.
Department of Otorhinolaryngology Head and Neck Surgery, Provincial Hospital affiliated to Shandong University, Shandong Provincial Key Laboratory of Otology, Jinan 250021, China; Email:
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Sep;50(9):733-7.
To explore the long-term efficacy and safety of triple semicircular canal occlusion (TSCO) in the treatment of intractable Meniere's disease (MD) so as to provide an alternative surgical procedure for treating this disorder.
Data from Forty-nine patients, who were referred to our hospital and diagnosed with unilateral MD strictly meeting the criteria issued by Chinese Academy of Otolaryngology-Head and Neck Surgery Committee (2006) from Dec. 2010 to Jul. 2012, were retrospectively analyzed in this work. Forty-nine patients, in whom the standardized conservative treatment was given at least one year and frequent vertigo still occurred, received TSCO. Vertigo control and auditory function were measured. Pure tone audiometry, caloric test, and cervical vestibular evoked myogenic potential (cVEMP) were performed for evaluation of audiological and vestibular function. Magnetic resonance hydrograph of inner ear was performed in patients received TSCO after 2 years for the observation of morphology of membranous labyrinth. Postoperative follow-up period was more than 2 years.
According to the preoperative staging of hearing, among these 49 patients, there were 2 cases in stage II (with an average hearing threshold of 25-40 dBHL), 40 in stage III (41-70 dBHL) and 7 in stage IV (over 70 dBHL). Vertigo was controlled effectively in all 49 cases in two-year follow-up, of which 40 cases (81.6%) were completely controlled and 9 cases (18.4%) were substantially controlled after surgery. The rate of hearing preservation was 69.4% and the rate of hearing loss was 30.6%. Post-operatively, all patients suffered from temporary vertigo and balance disorders. Vertigo was disappeared in all patients within 3-5 days, while averagely recovered after 13.5 days. Two years afer treatment, loss of semicircular canal function by caloric test was found in the operation side of all patients and no change in cVEMP test was noted. All patients had no facial paralysis, cerebrospinal fluid leakage, and other complications. Magnetic resonance hydrograph of inner ear showed that endolymph fluid in the position of plugging had no water after 2-years of TSCO.
TSCO, which can reduce vertiginous symptoms effectively in patients with intractable MD in long-term follow-up, represents an effective and safe therapy for this disorder. TSCO is expected to be used as an alternative procedure for the treatment of MD in selected patients suffering from severe hearing loss or recurrence after endolymphatic sac surgery.
探讨半规管阻塞术(TSCO)治疗难治性梅尼埃病(MD)的长期疗效及安全性,为该疾病的治疗提供一种新的手术方式。
回顾性分析2010年12月至2012年7月在我院就诊并严格按照中华医学会耳鼻咽喉头颈外科学分会(2006版)标准诊断为单侧MD的49例患者资料。49例患者均接受了至少1年的规范化保守治疗,仍频繁发作眩晕,遂行TSCO治疗。观察眩晕控制及听力情况。采用纯音听阈测试、冷热试验及颈肌前庭诱发肌源性电位(cVEMP)评估听力学及前庭功能。TSCO术后2年行内耳磁共振水成像观察膜迷路形态。术后随访时间均超过2年。
根据术前听力分期,49例患者中,Ⅱ期2例(平均听阈25~40 dBHL),Ⅲ期40例(41~70 dBHL),Ⅳ期7例(>70 dBHL)。随访2年,49例患者眩晕均得到有效控制,其中40例(81.6%)完全控制;9例(18.4%)基本控制。听力保留率为69.4%,听力下降率为30.6%。术后所有患者均出现短暂眩晕及平衡障碍,眩晕均在3~5天内消失,平均13.5天恢复。治疗2年后,所有患者手术侧冷热试验均提示半规管功能丧失,cVEMP测试无变化。所有患者均未出现面瘫、脑脊液漏等并发症。内耳磁共振水成像显示TSCO术后2年堵塞部位内淋巴液无水样信号。
TSCO可有效减轻难治性MD患者的眩晕症状,是一种有效、安全的治疗方法。对于重度听力下降或内淋巴囊手术后复发的MD患者,TSCO有望成为一种可供选择的治疗手段。